Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8263154rdf:typepubmed:Citationlld:pubmed
pubmed-article:8263154lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:8263154lifeskim:mentionsumls-concept:C0001527lld:lifeskim
pubmed-article:8263154lifeskim:mentionsumls-concept:C0025255lld:lifeskim
pubmed-article:8263154lifeskim:mentionsumls-concept:C0017687lld:lifeskim
pubmed-article:8263154lifeskim:mentionsumls-concept:C0597357lld:lifeskim
pubmed-article:8263154lifeskim:mentionsumls-concept:C0002482lld:lifeskim
pubmed-article:8263154lifeskim:mentionsumls-concept:C0150312lld:lifeskim
pubmed-article:8263154pubmed:issue6lld:pubmed
pubmed-article:8263154pubmed:dateCreated1994-1-24lld:pubmed
pubmed-article:8263154pubmed:abstractTextSpecific receptors for glucagon and for glucagon-like peptide-1 (GLP-1) (7-36)amide have been found in solubilized human adipose membranes. The 50% inhibition dose of the corresponding unlabeled peptide was near to their physiological levels [ID50, 0.5 nmol/L for glucagon and 1.0 nmol/L for GLP-1(7-36)amide;]. In both cases, the presence of high affinity receptors was evident [Kd, 0.5 and 0.7 nmol/L for glucagon and GLP-1(7-36)amide, respectively]; the high affinity maximal binding capacity for GLP-1(7-36)amide was higher than that for glucagon (893 and 117 fmol/mg solubilized fat membranes, respectively). Glucagon at 10(-6) mol/L did not compete with the [125I]GLP-1(7-36)amide binding, nor did GLP-1(7-36)amide (10(-6) mol/L) compete with that of [125I]glucagon. The relative abundance of GLP-1(7-36)amide receptors in human adipose tissue is further support for a direct and probably important action of this peptide in the metabolism of the fat cell.lld:pubmed
pubmed-article:8263154pubmed:languageenglld:pubmed
pubmed-article:8263154pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8263154pubmed:citationSubsetAIMlld:pubmed
pubmed-article:8263154pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8263154pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8263154pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8263154pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8263154pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8263154pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8263154pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8263154pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8263154pubmed:statusMEDLINElld:pubmed
pubmed-article:8263154pubmed:monthDeclld:pubmed
pubmed-article:8263154pubmed:issn0021-972Xlld:pubmed
pubmed-article:8263154pubmed:authorpubmed-author:ValverdeIIlld:pubmed
pubmed-article:8263154pubmed:authorpubmed-author:MolinaL MLMlld:pubmed
pubmed-article:8263154pubmed:authorpubmed-author:DelgadoEElld:pubmed
pubmed-article:8263154pubmed:authorpubmed-author:MéridaEElld:pubmed
pubmed-article:8263154pubmed:authorpubmed-author:Villanueva-Pe...lld:pubmed
pubmed-article:8263154pubmed:issnTypePrintlld:pubmed
pubmed-article:8263154pubmed:volume77lld:pubmed
pubmed-article:8263154pubmed:ownerNLMlld:pubmed
pubmed-article:8263154pubmed:authorsCompleteYlld:pubmed
pubmed-article:8263154pubmed:pagination1654-7lld:pubmed
pubmed-article:8263154pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:8263154pubmed:meshHeadingpubmed-meshheading:8263154-...lld:pubmed
pubmed-article:8263154pubmed:meshHeadingpubmed-meshheading:8263154-...lld:pubmed
pubmed-article:8263154pubmed:meshHeadingpubmed-meshheading:8263154-...lld:pubmed
pubmed-article:8263154pubmed:meshHeadingpubmed-meshheading:8263154-...lld:pubmed
pubmed-article:8263154pubmed:meshHeadingpubmed-meshheading:8263154-...lld:pubmed
pubmed-article:8263154pubmed:meshHeadingpubmed-meshheading:8263154-...lld:pubmed
pubmed-article:8263154pubmed:meshHeadingpubmed-meshheading:8263154-...lld:pubmed
pubmed-article:8263154pubmed:meshHeadingpubmed-meshheading:8263154-...lld:pubmed
pubmed-article:8263154pubmed:meshHeadingpubmed-meshheading:8263154-...lld:pubmed
pubmed-article:8263154pubmed:meshHeadingpubmed-meshheading:8263154-...lld:pubmed
pubmed-article:8263154pubmed:meshHeadingpubmed-meshheading:8263154-...lld:pubmed
pubmed-article:8263154pubmed:meshHeadingpubmed-meshheading:8263154-...lld:pubmed
pubmed-article:8263154pubmed:meshHeadingpubmed-meshheading:8263154-...lld:pubmed
pubmed-article:8263154pubmed:year1993lld:pubmed
pubmed-article:8263154pubmed:articleTitlePresence of glucagon and glucagon-like peptide-1-(7-36)amide receptors in solubilized membranes of human adipose tissue.lld:pubmed
pubmed-article:8263154pubmed:affiliationFundación Jiménez Díaz, Madrid, Spain.lld:pubmed
pubmed-article:8263154pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8263154pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8263154lld:pubmed